Examining the implementation of RWD quality frameworks in oncology becarispublishing.com/digital-cont...

Key takeaways from the GetReal Conference 2026: From JCA to post-approval evidence becarispublishing.com/digital-cont...

NIH expands All of Us into the world’s largest integrated genomic and EHR research database becarispublishing.com/digital-cont...

Samsung and Alcedis to advance wearable-based endpoints in clinical research becarispublishing.com/digital-cont...

Two discontinued JCAs reveal emerging evidence standards as EU HTA assessments gather pace becarispublishing.com/digital-cont...

Insights into ALZ-NET and real-world evidence generation in Alzheimer’s disease: A conversation with Rebecca Edelmayer, @alzassociation.bsky.social becarispublishing.com/digital-cont...

Improving transparency in target trial emulation: The TARGET guideline with Aidan Cashin, University of New South Wales becarispublishing.com/digital-cont...

Examining the feasibility of external control arms across data sources in oncology becarispublishing.com/digital-cont...

EFPIA report highlights widening disparities in access to innovative medicines across Europe becarispublishing.com/digital-cont...

UK’s MHRA and @NICE formalize early RWE dialogue initiative following pilot Read here: becarispublishing.com/digital-cont... @nicecomms.bsky.social @mhragovuk.bsky.social

Trump Administration outlines projected savings from MFN drug pricing framework becarispublishing.com/digital-cont...

New HEMA project to assess approaches for handling uncertainty in economic evaluation becarispublishing.com/digital-cont...

TEHDAS2 joint action has launched the final consultation phase to support implementation of the #EHDS for secondary use of health data. ➡️ Seven draft guidelines. ➡️ Reflects the move from policy development toward practical implementation. @tehdas.eu becarispublishing.com/digital-cont...

Strengthening research through meaningful public and patient involvement - key discussions from the recent webinar by @claremontcomms.bsky.social becarispublishing.com/digital-cont...

What to attend at ISPOR 2026: Exploring the conference program with @ispor.bsky.social's Laura Pizzi becarispublishing.com/digital-cont...

UK Biobank data breach raises renewed questions in safeguarding secondary health data | Becaris Publishing becarispublishing.com/digital-cont...

Is expanded access to GLP-1 medicines hanging in the BALANCE as CMS delays its payment and coverage model? | Becaris Publishing becarispublishing.com/digital-cont...

Perspectives from the Healthcare Economist: Two visions for value – Why GCEA and HEMA clash on drug pricing | Becaris Publishing becarispublishing.com/digital-cont...

A new framework for patient engagement in rare disease HTA: Rick Chapman and Michelle Cheng of IVI on the Rare Disease Patient Engagement Guidance and Checklist | Becaris Publishing becarispublishing.com/digital-cont...

FDA shares insights on growing use of real-world evidence in medical device approvals | Becaris Publishing becarispublishing.com/digital-cont...

Value Viewpoint: Prying open the pharmacy benefit manager black box to decode the 2026 PBM reforms | Becaris Publishing becarispublishing.com/digital-cont...

Can I trust agentic AI? Validating autonomous analytics for real-world data | Becaris Publishing becarispublishing.com/digital-cont...

EMA publishes final real world data chapter of EU Data Quality Framework | Becaris Publishing becarispublishing.com/digital-cont...

New ABPI report sets out plan to accelerate UK clinical trials using NHS data | Becaris Publishing becarispublishing.com/digital-cont...

New real-world data platform launched to support Alzheimer’s research | Becaris Publishing becarispublishing.com/digital-cont...

Your guide to the World Evidence, Pricing and Access Congress 2026: Key sessions on RWE, AI, launch strategies, rare diseases and patient centricity becarispublishing.com/digital-cont...

Your guide to the World Evidence, Pricing and Access Congress 2026: Key sessions on pricing, EU HTA, innovation and sustainability becarispublishing.com/digital-cont... #WorldEPACongress #MarketAccess #HTA

Market access and HTA developments with Sreeram Ramagopalan: US–UK policy updates and evolving US drug pricing reforms | Becaris Publishing becarispublishing.com/digital-cont...

ISPOR’s Laura Pizzi and Mitch Higashi on the 2026–2027 Top 10 HEOR Trends and their implications for evidence and access @ispor.bsky.social becarispublishing.com/digital-cont...

Gamechanger for UK research as NHS England advances consented GP data access | Becaris Publishing becarispublishing.com/digital-cont...

📢New article alert Treatment burden and healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps who did or did not undergo functional endoscopic sinus surgery: a US real-world retrospective cohort study 🔗 becarispublishing.com/doi/10.57264... #OpenAccess #JCER

Why misaligned evidence strategies delay #PatientAccess to medicines | Becaris Publishing becarispublishing.com/digital-cont...

BC Platforms and OmicsBank launch collaboration to grow real-world and multi-omics evidence from India and the UAE | Becaris Publishing becarispublishing.com/digital-cont...

TrumpRx launches to lower US drug prices, but early reaction is mixed | Becaris Publishing becarispublishing.com/digital-cont... #DrugPricing #MFN #MostFavoredNation #MarketAccess

#RareDisease outcome assessment under #EUHTA and #JointClinicalAssessment | Becaris Publishing becarispublishing.com/digital-cont...

Hot off the press: Part one of our pick of articles within #HTA and #RWE published in January 2026 | Becaris Publishing becarispublishing.com/digital-cont...

📢New article alert New Perspective article on "Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial" 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess #JCER #TrialMethodology #RealWorldEvidence #RWE

Head-to-head real-world study reports overall survival advantage with apalutamide compared with darolutamide in metastatic castration-sensitive #ProstateCancer | Becaris Publishing becarispublishing.com/digital-cont...

#IndustryUpdate tracker: January 2026 | Becaris Publishing becarispublishing.com/digital-cont...

Patient roles and expectations in effective #HTA engagement | Becaris Publishing becarispublishing.com/digital-cont...

📢New article alert New Research Article on “Indirect comparisons of tucatinib in combination with trastuzumab for patients with previously treated HER2–positive metastatic colorectal cancer”. 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess #JCER #ColorectalCancer #Oncology #ITC

#CMS announces drugs selected for third cycle of #Medicare #DrugPrice negotiations | Becaris Publishing becarispublishing.com/digital-cont...

📢New Research Article alert "Acthar Gel versus standard of care for adults with proteinuria in nephrotic syndrome due to focal segmental glomerulosclerosis: cost-per-response analysis from the US healthcare perspective" 🔗 becarispublishing.com/doi/10.57264... #OpenAccess #JCER #KidneyDisease

Modeling #caregiver quality of life in #HTA: Why economic models struggle to reflect lived experience | Becaris Publishing becarispublishing.com/digital-cont...

📢New article alert New Short Report on "First-line tumor necrosis factor inhibitor versus abatacept treatment choice in real-world patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis". 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess

New in the Journal of Comparative Effectiveness Research: Video Snapshots | Becaris Publishing becarispublishing.com/digital-cont...

FDA draft guidance clarifies use of Bayesian methods in #ClinicalTrials | Becaris Publishing becarispublishing.com/digital-cont...

📢New article alert New Review article on “Reshaping the cardiovascular continuum in the management of arterial and venous cardiovascular disease: a narrative review”. 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess #JCER #CardiovascularDisease #Prevention #IntegratedCare

Health Canada opens consultation on draft guidance for decentralized clinical trials | Becaris Publishing becarispublishing.com/digital-cont...

📢New article alert New Research Article on “The impact of socioeconomic crisis on cancer patient outcomes in Lebanon, 2018–2020”. 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess #JCER #Oncology #GlobalHealth #HealthEquity #HealthPolicy